首页> 外文期刊>Journal of cellular biochemistry. >Fibrin glue mediated delivery of bone anabolic reagents to enhance healing of tendon to bone
【24h】

Fibrin glue mediated delivery of bone anabolic reagents to enhance healing of tendon to bone

机译:纤维蛋白胶水介导的骨合成代谢试剂递送,以增强肌腱愈合骨骼

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Abstract Tendon graft healing in bone tunnels for the fixation of intra‐articular ligament reconstructions may limit clinical outcome by delaying healing. This study assesses the effects of hydrogel‐mediated delivery of bone anabolic growth factors in a validated model of tendon‐to‐bone tunnel healing. Forty‐five Wistar rats were randomly allocated into three groups (BMP2‐treated, GSK126‐treated, and placebo). All animals underwent a tendon‐to‐bone tunnel reconstruction. Healing was evaluated at 4 weeks by biomechanical assessment, micro‐computed tomography (bone mineral density, bone volume, cross sectional area of bone tunnels), and traditional histology. Adverse events associated with the hydrogel‐mediated delivery of drugs were not observed. Results of our biomechanical assessment demonstrated favorable trends in animals treated with bone anabolic factors for energy absorption ( P ?=?0.116) and elongation ( P ?=?0.054), while results for force to failure ( P ?=?0.691) and stiffness ( P ?=?0.404) did not show discernible differences. Cross sectional areas for BMP2‐treated animals were reduced, but neither BMP2 nor GSK126 administration altered bone mineral density ( P ?=?0.492) or bone volume in the bone tunnel. These results suggest a novel and positive effect of bone anabolic factors on tendon‐to‐bone tunnel healing. Histological evaluation confirmed absence of collagen fibers crossing the soft tissue‐bone interface indicating immature graft integration as expected at this time point. Our study indicates that hydrogel‐mediated delivery of BMP2 and GSK126 appears to be safe and has the potential to enhance tendon‐to‐bone tunnel healing in ligament reconstructions.
机译:摘要在骨隧道中愈合骨隧道,用于固定关节内韧带重建可能会通过延迟愈合来限制临床结果。该研究评估了水凝胶介导的骨骼合成术生长因子递送在肌腱对骨隧道愈合验证模型中的影响。将四十五只Wistar大鼠随机分配到三组(BMP2处理,GSK126处理和安慰剂)中。所有动物都经历了肌腱 - 骨隧道重建。通过生物力学评估,微型计算机断层扫描(骨矿物质密度,骨隧道骨骼,骨隧道横截面积)和传统组织学评估愈合。未观察到与水凝胶介导的药物相关的不良事件。我们的生物力学评估结果表明了用骨骼合成因子治疗的动物的良好趋势(p?= 0.116)和伸长率(p?= 0.054),而力量发生故障(p?= 0.691)和刚度(p?= 0.404)没有显示出可辨别的差异。降低了BMP2处理动物的横截面积,但BMP2和GSK126给药都没有改变骨矿物密度(P?= 0.492)或骨隧道中的骨体积。这些结果表明骨骼合成因素对肌腱对骨隧道愈合的新颖和积极作用。组织学评估证实没有胶原纤维的不存在,其在这种时间点预期表示未成熟的接枝整合的软组织骨界面。我们的研究表明,水凝胶介导的BMP2和GSK126的递送似乎是安全的,并且有可能在韧带重建中增强肌腱对骨隧道愈合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号